Lyme disease vaccine - Sanofi
Alternative Names: ImuLymeLatest Information Update: 06 Apr 2022
At a glance
- Originator Symbicom
- Developer sanofi pasteur
- Class Bacterial vaccines; Lyme disease vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Lyme disease